Corporate Banner
Satellite Banner
Technology Networks Header
Friday, September 19, 2014
 
Register | Sign in
Home Page>Products
  Product News
New Application Note for TAP’s ambr15 Micro Bioreactors
Friday, September 12, 2014
Provides tips on how to maximize data collection with minimum sample volume and smart sampling regimes.

Quickly Identify Rhodamine B in Cosmetics
Friday, September 12, 2014
Determination of Rhodamine B using a rapid separation liquid chromatography column.

Unmatched Deep Imaging of Biological Samples
Friday, September 12, 2014
Olympus launches its dedicated multiphoton excitation (MPE) objectives for deep imaging.

Need to Cut Patient Readmissions? There's an App for That
Friday, September 12, 2014
Aridhia transforms Nuffield’s readmission risk model into an online app designed to reduce number of patients readmitted to hospital within 30 days.

Agilent Introduces Modular Real-Time PCR System
Friday, September 12, 2014
Instrument Provides High Resolution, Less Interference Between Channels.

Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.

Agilent Introduces Next-Generation UHPLC System
Friday, September 12, 2014
Company will introduce its latest innovation on Sept. 23 at Analytica China in Shanghai.

Artel Expands Software Development and Support Team
Thursday, September 11, 2014
Greg Fischer joins Company as software project manager.

PerkinElmer Launches Innovative Solaris™ Optical Imaging System
Thursday, September 11, 2014
Fluorescence technology for small and large animal imaging advances translational and preclinical research applications.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 10499
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv